Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA known ✓ | P10253 | 1/20 | 0.49 |
| ▸ | HRH3 known ✓ | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 8/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.58 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | RECQL | P46063 | 1/20 | 0.58 |
| ▸ | GSTM2 | P28161 | 1/20 | 0.56 |
| ▸ | MYC | P01106 | 9/20 | 0.53 |
| ▸ | MAX | P61244 | 5/20 | 0.53 |
| ▸ | IDO1 | P14902 | 3/20 | 0.52 |
| ▸ | MIF | P14174 | 1/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.49 |
| ▸ | PSMD14 | O00487 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1071568 | 0.99 | MEN1 (0.59) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL597411 | 0.99 | MEN1 (0.59) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL5323052 | 0.89 | GSTM2 (0.61) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL10824789 | 0.82 | MEN1 (0.66) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL22443336 | 0.82 | MAPT (0.42) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL7858944 | 0.79 | MAPT (0.42) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL17525024 | 0.78 | GSTM2 (0.67) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL13589830 | 0.76 | GSTM2 (0.62) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL8427049 | 0.76 | GSTM2 (0.81) | MEN1KMT2AUSP2HTTRECQL | |
| SCHEMBL8429536 | 0.76 | GSTM2 (0.68) | MEN1KMT2AUSP2HTTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250354192-A1 | METHODS FOR QUANTIFYING LIVE BACTERIA | ANCERA INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4540404-A1 | METHODS FOR QUANTIFYING LIVE BACTERIA | Ancera Inc. (US) | 2025-04-23 | — | — | EP | disclosed |
| WO-2025006923-A2 | SINGLE-STRANDED NUCLEIC ACID ANALOGS FOR USE AS MUTATION RESISTANT ANTIBACTERIAL TREATMENT | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2025-01-02 | — | — | WO | disclosed |
| US-20240327850-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING RELEASE FACTOR ACTIVITY AND USES THEREOF | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-10-03 | — | — | US | disclosed |
| US-20240271122-A1 | METHODS FOR CODON OPTIMIZATION AND USES THEREOF | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-08-15 | — | — | US | disclosed |
| US-20240158735-A1 | METHODS AND COMPOSITIONS USING AN ENGINEERED RELEASE FACTOR | OXFORD FINANCE LLC, AS COLLATERAL AGENT | 2024-05-16 | — | — | US | disclosed |
| WO-2023245172-A1 | METHODS FOR QUANTIFYING LIVE BACTERIA | ANCERA INC. (US) | 2023-12-21 | — | — | WO | disclosed |
| WO-2022235825-A1 | METHODS AND COMPOSITIONS FOR CONTROLLING RELEASE FACTOR ACTIVITY AND USES THEREOF | Opentrons LabWorks Inc. (US) | 2022-11-10 | — | — | WO | disclosed |
| WO-2022221576-A1 | METHODS FOR CODON OPTIMIZATION AND USES THEREOF | Opentrons LabWorks Inc. (US) | 2022-10-20 | — | — | WO | disclosed |